To Screen or Not to Screen
When investigating HAI outbreaks, your decisions have significant consequences. Implementing disruptive precautionary measures without confirming clonality can be costly and unnecessary. But failing to deal with real outbreaks early can lead to patient safety concerns and financial penalties. EpiXact®, our rapid turnaround, whole-genome sequencing service for HAI investigations, provides you...
Just can’t seem to shake it off?
If you’ve been in infection control for a while, you...
What is up with NTM?
Recently, we received multiple requests to help with...
Sign-Up to Receive the Monthly SNPIT Newsletter
Unmasking promiscuous bacterial species in HAI investigations
When it comes to determining relatedness between isolates in an HAI investigation, you know by now...
Stop HAIs in their tracks…
As the pandemic starts to clear, infection control and microbiology labs are finally getting a...
Sequencing costs are down to $0…
We always believed that whole genome sequencing based surveillance would be the most...
PFGE, MLST and the Alphabet Soup of HAIs
It can be confusing to make sense of the alphabet soup of methods used to test if samples are...
Looking for STEC in all the right places
Fecal microbiota transplants (FMT) are remarkably effective treatment options for recurrent C....
When is a MRSA not a MRSA?
Hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) infections remain a...
Rooting Out Carbapenem-Resistant Acinetobacter baumannii from Environmental Reservoirs
Rooting Out Carbapenem-Resistant Acinetobacter baumannii from Environmental Reservoir. A recent...
It’s about time… Get started with epiXact today.
In today's unprecedented times, infection control is more critical than ever. While COVID-19 is...